Rexall's Jeffery to retire

October 3rd, 2011

TORONTO – Retail pharmacy industry veteran Warren Jeffery plans to retire from Katz Group Canada Ltd./Rexall at the end of this month.

Warren Jeffery

The Canadian chain drug retailer said Monday that Jeffery, who currently serves as chief development officer and interim chief merchandising officer, is slated to retire Oct. 31 after seven years with the company, including a stint as chief operating officer for the Rexall corporate store division.

"I feel honored to have been a part of the growth of Rexall in Canada," Jeffery said in a statement. "There is a strong management team at Rexall and a genuine dedication to improving patient care and delivering a superior customer experience. I am appreciative of the role I've played in the organization's development."

Jeffery's retail pharmacy career spans 35 years. According to Katz, he joined Rexall with a mandate to bolster the drug store chain's corporate store operations and has since helped it achieve significant gains in store capabilities, strategies and processes in operations, real estate, acquisitions and pharmacy services.

Katz noted that Jeffery was pivotal in the rollout of more than 200 prototype stores, the
development of progressive employer‐based and specialty programs, and the launch of Rexall Reminder Ready, a first-to-market medication compliance program. He also was the executive sponsor for Rexall's Healthy Living Store prototype. Overall, Rexall's network encompasses more than 1,800 chain, franchise and independent pharmacies across Canada, under the banners Rexall, Rexall Pharma Plus, The Medicine Shoppe, Guardian and I.D.A.

Before coming to Katz, Jeffery served in senior executive roles in operations, merchandising and marketing at retail pharmacy chains including Perry Drug Stores, Revco Drug Stores and Phar‐Mor Deep Discount Food & Drug as well as at McKesson Corp.

"We thank Warren for his contributions and his leadership," Katz Group Canada chief executive officer Andy Giancamilli stated. "Warren has been at the helm of key organizational initiatives that has driven innovation in pharmacy care, improved medication compliance and has set a solid foundation for future organizational growth. We wish him all the best in his retirement."

Jeffery's retirement continues a leadership transition at Katz/Rexall. In mid-September, the drug chain announced that Giancamilli will retire as CEO early next year and be succeeded by chief operating officer Frank Scorpiniti.

Scorpiniti joined Katz as COO in April from Duane Reade, where he was senior vice president of pharmacy operations. In announcing Scorpiniti's hiring, Katz also appointed Jeffery as chief development officer and said he would add that role to his responsibilities as interim chief merchandising officer.